BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 32445446)

  • 1. Gonadotropin Treatment for the Male Hypogonadotropic Hypogonadism.
    Boeri L; Capogrosso P; Salonia A
    Curr Pharm Des; 2021; 27(24):2775-2783. PubMed ID: 32445446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testicular growth and spermatogenesis: new goals for pubertal hormone replacement in boys with hypogonadotropic hypogonadism? -a multicentre prospective study of hCG/rFSH treatment outcomes during adolescence.
    Rohayem J; Hauffa BP; Zacharin M; Kliesch S; Zitzmann M;
    Clin Endocrinol (Oxf); 2017 Jan; 86(1):75-87. PubMed ID: 27467188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Causes of hypogonadotropic hypogonadism predict response to gonadotropin substitution in adults.
    Rohayem J; Sinthofen N; Nieschlag E; Kliesch S; Zitzmann M
    Andrology; 2016 Jan; 4(1):87-94. PubMed ID: 26779870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism.
    Liu L; Banks SM; Barnes KM; Sherins RJ
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1140-5. PubMed ID: 3142911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulsatile GnRH or human chorionic gonadotropin/human menopausal gonadotropin as effective treatment for men with hypogonadotropic hypogonadism: a review of 42 cases.
    Büchter D; Behre HM; Kliesch S; Nieschlag E
    Eur J Endocrinol; 1998 Sep; 139(3):298-303. PubMed ID: 9758439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of gonadotropin releasing hormone in hypogonadotropic hypogonadism--diagnostic and therapeutic aspects.
    Delemarre-van de Waal HA
    Eur J Endocrinol; 2004 Nov; 151 Suppl 3():U89-94. PubMed ID: 15554892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormonal control of spermatogenesis in men: therapeutic aspects in hypogonadotropic hypogonadism.
    Pitteloud N; Dwyer A
    Ann Endocrinol (Paris); 2014 May; 75(2):98-100. PubMed ID: 24793994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of gonadotropin-deficient boys with recombinant human FSH: long-term observation and outcome.
    Raivio T; Wikström AM; Dunkel L
    Eur J Endocrinol; 2007 Jan; 156(1):105-11. PubMed ID: 17218732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gonadotropins for pubertal induction in males with hypogonadotropic hypogonadism: systematic review and meta-analysis.
    Alexander EC; Faruqi D; Farquhar R; Unadkat A; Ng Yin K; Hoskyns R; Varughese R; Howard SR
    Eur J Endocrinol; 2024 Jan; 190(1):S1-S11. PubMed ID: 38128110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maintenance of spermatogenesis in hypogonadotropic hypogonadal men with human chorionic gonadotropin alone.
    Depenbusch M; von Eckardstein S; Simoni M; Nieschlag E
    Eur J Endocrinol; 2002 Nov; 147(5):617-24. PubMed ID: 12444893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of puberty with human chorionic gonadotropin and follicle-stimulating hormone in adolescent males with hypogonadotropic hypogonadism.
    Barrio R; de Luis D; Alonso M; Lamas A; Moreno JC
    Fertil Steril; 1999 Feb; 71(2):244-8. PubMed ID: 9988392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seminal anti-Müllerian hormone level is a marker of spermatogenic response during long-term gonadotropin therapy in male hypogonadotropic hypogonadism.
    Sinisi AA; Esposito D; Maione L; Quinto MC; Visconti D; De Bellis A; Bellastella A; Conzo G; Bellastella G
    Hum Reprod; 2008 May; 23(5):1029-34. PubMed ID: 18343809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormonal replacement therapy with HCG and HU-FSH in thalassaemic patients affected by hypogonadotropic hypogonadism.
    Cisternino M; Manzoni SM; Coslovich E; Autelli M
    J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():885-90. PubMed ID: 10091162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Male hypogonadotropic hypogonadism: factors influencing response to human chorionic gonadotropin and human menopausal gonadotropin, including prior exogenous androgens.
    Ley SB; Leonard JM
    J Clin Endocrinol Metab; 1985 Oct; 61(4):746-52. PubMed ID: 3928676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of gonadotropin-replacement therapy in male patients with hypogonadotropic hypogonadism.
    Ortac M; Hidir M; Salabas E; Boyuk A; Bese C; Pazir Y; Kadioglu A
    Asian J Androl; 2019; 21(6):623-627. PubMed ID: 31062720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible role of
    Firouzi V; Borjian Boroujeni P; Rokhsat Talab Z; Mohammadi M; Sadighi Gilani MA; Sabbaghian M; Mohseni Meybodi A
    Syst Biol Reprod Med; 2019 Aug; 65(4):326-332. PubMed ID: 31030566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormonal regulation of male reproduction (with reference to infertility in man).
    Courot M
    Andrologia; 1976; 8(3):187-93. PubMed ID: 999040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of hormonal treatment in hypogonadotropic hypogonadism: more than ten years experience.
    Yang L; Zhang SX; Dong Q; Xiong ZB; Li X
    Int Urol Nephrol; 2012 Apr; 44(2):393-9. PubMed ID: 21989858
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.